Cargando…
Effect of Donepezil on Cognitive Impairment, Quality of Life, and Depression in Multiple Sclerosis Patients: A Randomized Clinical Trial
BACKGROUND: Cognitive impairment is one of the debilitating consequences of multiple sclerosis (MS) with negative effects on daily life, individual and social activities, quality of life (QOL), and depression. No approved medication is introduced so far for affected individuals. We aimed to evaluate...
Autores principales: | Shahpouri, Mohammad Mahdi, Barekatain, Majid, Tavakoli, Mahgol, Badihian, Shervin, Shaygannejad, Vahid |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7373083/ https://www.ncbi.nlm.nih.gov/pubmed/32742613 http://dx.doi.org/10.4103/ijpvm.IJPVM_154_19 |
Ejemplares similares
-
Comparison of Cognitive Rehabilitation versus Donepezil Therapy on Memory Performance, Attention, Quality of Life, and Depression among Multiple Sclerosis Patients
por: Shahpouri, Mohammad Mahdi, et al.
Publicado: (2020) -
Evaluation of cognitive rehabilitation on the cognitive performance in multiple sclerosis: A randomized controlled trial
por: Shahpouri, Mohammad Mahdi, et al.
Publicado: (2019) -
Cognitive rehabilitation in patients with nonamnestic mild cognitive impairment
por: Barekatain, Majid, et al.
Publicado: (2016) -
Memory specificity training can improve working and prospective memory in amnestic mild cognitive impairment
por: Emsaki, Golita, et al.
Publicado: (2017) -
The efficacy of transdiagnostic cognitive behavioral therapy on migraine headache: a pilot, feasibility study
por: Soleimanian-Boroujeni, Forouzandeh, et al.
Publicado: (2022)